Additional Content
THIRD BRIDGE IN THE NEWS
Fierce Pharma: Pharma’s Q3 growth rankings: GLP-1 drugs from Eli Lilly, Novo Nordisk were once again the big story
THIRD BRIDGE IN THE NEWS
The FT: Letter: Blockbuster drugs are one thing, but lifestyles must change too
THIRD BRIDGE IN THE NEWS
Bloomberg: Zoom’s third quarter beats estimates
THIRD BRIDGE IN THE NEWS
Bloomberg: Disney to host town hall to discuss future projects
THIRD BRIDGE IN THE NEWS
City AM: UBS swings to bigger-than-expected £637m loss after costly Credit Suisse integration
THIRD BRIDGE IN THE NEWS
Bloomberg: Disney reports Q4 earnings results
THIRD BRIDGE IN THE NEWS
Fierce Pharma: Gilead execs muse over ‘surprising’ lack of CAR-T adoption in certain patients, US barriers to uptake
THIRD BRIDGE IN THE NEWS
